RANI - Shares of Rani Therapeutics Holdings Inc. (RANI) Rise Above Previous 52-Week High
Rani Therapeutics Holdings Inc. (NASDAQ:RANI) traded at a new 52-week high today of $34.50. Approximately 881,000 shares have changed hands today, as compared to an average 30-day volume of 57,000 shares.
Over the past year, Rani Therapeutics Holdings Inc. has traded in a range of $9.24 to $34.50 and is now at $32.00, 246% above that low.
Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. It has developed the RaniPill capsule, proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing.
Rani Therapeutics Holdings Inc. (NASDAQ:RANI) is currently priced 30.5% above its average consensus analyst price target of $22.25.
Receive IBN Spotlights - "Bite Size" Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About IBN (InvestorBrandNetwork)
IBN consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and Code Editorial Syndication to 5,000+ broadcast outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign and the NEW normal.
For more information on IBN, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer